Advanced Drug Formulation Design to Optimize Therapeutic Outcomes

Contributor(s):

Material type: Text

TextPublication details: New York Informa Healthcare USA, Inc. 2008Description: 510pISBN:

9781420043877

Subject(s):

Drug Formulations

DDC classification:

615.14 ADV

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Item location	Collection	Call number	Status	Date due	Barcode	Item holds
Reference Book	NIMA Knowledge Centre	6th Floor Silence Zone	Reference	615.14 ADV (Browse shelf(Opens below))	Not For Loan		P0005165

Total holds: 0

Browsing Institute of Pharmacy shelves, Collection: Reference Close shelf browser (Hides shelf browser)

Previous								Next
Previous	615.11 USP The United States Pharmacopeia 42 Volume 5: NF 37 2019	615.11 USP The United States Pharmacopeia 42 NF 37 2019, First Supplement	615.1341 BRI British National Formulary: BNF 45 March 2003	615.14 ADV Advanced Drug Formulation Design to Optimize Therapeutic Outcomes	615.14 AKE Parenteral Quality Control: Sterility, Pyrogen, Particulate and Package Integrity Testing	615.14 AKE Parenteral Quality Control: Sterility, Pyrogen, Particulate and Package Integrity Testing	615.14 AKE Parenteral Quality Control: Sterility, Pyrogen, Particulate and Package Integrity Testing	Next

This title demonstrates how advanced formulation designs and delivery technologies can be used to improve drug efficacy and treatment outcomes in particular therapeutic categories or disease states. It discusses nanoparticle systems for cancer treatments, and also presents cutting edge immono-regulation agents for transplantation and the local targeting of drugs, especially poorly water soluble drugs to provide enhanced therapeutic outcomes. In addition, this title highlights areas of therapy showing the most promise for improvement in clinical outcomes via advanced formulation design.

There are no comments on this title.

to post a comment.